Controlling lung cancer in mice with milk thistle extract

Feb 16, 2011 By Lynn Clark

(PhysOrg.com) -- Silibinin, a milk thistle extract, decreases tumor size in mice by inhibiting production of an enzyme that is overexpressed in certain types cancer, researchers at the University of Colorado Cancer Center have found.

The study will be the featured highlight in the Feb. 15 issue of Clinical Research, a prestigious cancer journal. Rajesh Agarwal, PhD, professor of pharmaceutical sciences at the University of Colorado School of Pharmacy and co-leader of the CU Cancer Center’s cancer prevention & control program, led the study.

Agarwal’s team specializes in the chemopreventive benefits of silibinin and other nutraceuticals. In this study, the team found that silibinin could reduce the size and number of lung tumors in mice by inhibiting inducible nitric oxide synthase (iNOS). This enzyme produces nitric oxide, which is a free radical that can lead to the development of lung cancer.

“In our ongoing studies, we want to understand the sources of generation by focusing on lung tumor microenvironment and how silibinin affects that,” Agarwal says. “We are trying to reach down earlier in the cancer development to reach real chemoprevention.”

Silibinin reduced by 72 percent after 12 weeks of treatment in mice with tumors that contained iNOS. In mice whose lung cancer did not express iNOS, silibinin had no effect.
“The results support targeting iNOS with silibinin for controlling ,” Agarwal says.

The study also showed the benefit of using micro-CT to optimize treatment. Unlike MRI, which does not produce images clear enough to measure tumor size, micro-CT images “clearly distinguished lung tumors from surrounding tissue even without any contrast agent, and the reconstructed 3D pulmonary images easily differentiated tumors from blood vessels,” according to the study.

“This is a very powerful, real-time technique to measure the effectiveness of cancer treatment in a non-invasive manner,” Agarwal says.

Explore further: Study pinpoints microRNA tied to colon cancer tumor growth

Provided by University of Colorado Denver

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Immune system may impact tumor blood supply

Dec 15, 2010

Scientists at the Dana-Farber Cancer Institute may have uncovered a mechanism for blocking tumor angiogenesis that involves the patient’s immune system, according to findings published in Cancer Research, a journal of the ...

Recommended for you

Dog's epigenome gives clues to human cancer

51 minutes ago

The bond between humans and dogs is strong and ancient. From being the protector of the first herds in a faithful pet, dogs and people share many aspects of life. The relationship between the two species ...

Study pinpoints microRNA tied to colon cancer tumor growth

16 hours ago

Researchers at the University of Minnesota have identified microRNAs that may cause colon polyps from turning cancerous. The finding could help physicians provide more specialized, and earlier, treatment before colon cancer ...

User comments : 0